SR One Capital Fund I Aggregator LP 13D and 13G filings for Design Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-22 4:25 pm Purchase | 2022-12-19 | 13D | Design Therapeutics, Inc. DSGN | SR One Capital Fund I Aggregator LP | 6,550,226 11.710% | 908,750 (+16.11%) | Filing |
| 2021-04-09 3:38 pm Purchase | 2021-03-30 | 13D | Design Therapeutics, Inc. DSGN | SR One Capital Fund I Aggregator LP | 5,641,476 10.500% | 5,641,476 (New Position) | Filing |